Gene therapy for cancer halted after patient death
Two trials assessing gene therapy for blood cancer have been put on hold by the US Food and Drug Administration, following a patient fatality...
An approach to medicine based on grouping patients according to the characteristics of their disease or how they respond to particular treatments (or to prophylaxis). This enables the identification and development of measures that are most effective for particular groups of patients.
Two trials assessing gene therapy for blood cancer have been put on hold by the US Food and Drug Administration, following a patient fatality...
by Marcia Costa
Genes linked to 17 types of cancer have been mapped in a new Pathology Atlas by Swedish researchers...
by Rikita Patel
The IBM Watson supercomputer can analyse 160 hours' worth of genomic data in just ten minutes...
Genome-wide analysis in South Asian populations may provide insight into rare genetic diseases, suggests research...
by Jen Willows
The Chief Medical Officer of England's annual report has recommended that personalised medicine approaches be adopted widely within the NHS.
A packed public event, produced by the Progress Educational Trust in partnership with Genomics England, saw the Chief Medical Officer for England launch her report 'Generation Genome'...
A revolutionary vaccine uses the patient’s own immune response to target tumour cells and could be the first step in bespoke, precision medicine.
A new three-in-one blood test could progress personalised treatment for patients with prostate cancer...
A drug treatment for ovarian cancer has shown success against inherited breast cancer...
Two trials of a new gene therapy have successfully treated blood cancers in patients who were unresponsive to standard treatment...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.